john Posted April 2, 2003 Share Posted April 2, 2003 Clinical Trials (Listed on Acurian since March 25th) A Phase 2 Trial of Antisense Nucleotide to PKC-alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients with Advanced, Previously Untreated Non-Small Cell Lung Cancer: Berkeley, California Bakersfield, California Torrance, California Miami Beach, Florida Park Ridge, Illinois Chicago, Illinois Baltimore, Maryland Chattanooga, Tennessee Lubbock, Texas Charlottesville, Virginia Milwaukee, Wisconsin Non-Small Cell Lung Cancer - Open Label, Randomized, Phase II/III: Ft. Lauderdale, Florida Open-Label Study of ALIMTA (pemetrexed) and Cisplatin in chemonaive patients with malignant Pleural Mesothelioma.: Tulsa, Oklahoma Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.